Home
Genoptix

Genoptix Market Share Analysis for May 2026

neogenomics is a leader in precision oncology testing, empowering healthcare experts to optimize patient care.

Health > Biotechnology and Pharmaceuticals

Domaingenoptix.com

Year Founded1999

Employees201 - 500

Annual Revenue$100M - $200M

Genoptix

Genoptix (including company regionals)

genoptix.com

See more website traffic and engagement information

Genoptix Revenue up to May 2026 is 100M - 200M

revenue generated by Genoptix top domains

Genoptix top domains revenue over 3 years

Revenue for Genoptix top domains

genoptix.com100M - 200M

See more with Sales Intelligence

Total visits to Genoptix's top domains

Understand Genoptix market share and potential market reach.

Total visits last 3 months

No Data to Display

Avg. visit duration in Genoptix's top domains

Analyze Genoptix engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on Genoptix's top domains

See how Genoptix keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

No Data to Display

Genoptix top competitors by domain

Top similar sites in May 2026, ranked by their affinity

acorda.comCompany NameAcorda Therapeutics, Inc.Employees201 - 500HQUnited States, New York, ArdsleyAnnual revenue$100M - $200MTotal visits--Health > Biotechnology and Pharmaceuticals

Top technologies used by Genoptix

These are the website technologies, by industry, used by Genoptix top domains

Conversion & Analytics (3)

Google Analytics

Recruitment (3)

ADP

Advertising (2)

DoubleClick

Audio Video Media (2)

Vimeo

More Technologies

10

See all

News & Signals from Genoptix

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsGenoptix Inc. is developing clinical diagnostics for hematologic indications on Jun 1st '20.And in June the company announced that molecular testing company Genoptix, which focuses on hematologic and solid cancers was adopting Saphyr to develop clinical diagnostics for hematologic indications.

NewsNeogenomics Inc acquired Genoptix Inc. for $125M on Oct 23rd '18.NeoGenomics has agreed to acquire Carlsbad, California-based Genoptix, a clinical oncology lab, for $125 million in cash and 1 million shares of NeoGenomics common stock.

NewsGenoptix Inc. launched FDA-authorized BCR-ABL MRDx TFR Monitoring Test for patients with chronic myeloid leukemia on Sep 1st '18.Genoptix, Inc., a leading oncology diagnostic laboratory, announces the immediate availability of a proprietary, FDA-authorized BCR-ABL MRDx® TFR Monitoring Test for patients with chronic myeloid leukemia (CML) being treated with Tasigna®(nilotinib).